Compare Kalbe Farma Tbk (KLBF) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kalbe Farma Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 57.2× UBC Medical Indonesia Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 3.48M). Which is the better fit depends on your goals.
| KLBF | LABS | |
|---|---|---|
Market Cap | 33T | 576.7B |
Volume | 98.44M | 3.48M |
Lot | 984.38K | 34.82K |
Turnover | 70.64B | 522.79M |
Average Price | 717.58 | 150.13 |
Value | 70.64B | 522.79M |
Indicative Equilibrium Price | 720 | 148 |
Indicative Equilibrium Volume | 43.62K | 350 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kalbe Farma Tbk
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
